COMMUNIQUÉS West-GlobeNewswire

Alder BioPharmaceuticals® Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
30/08/2019
BOTHELL, Wash., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Transparency notification
30/08/2019
Mechelen, Belgium; 30 August 2019; 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from Van Herk Investments B.V . Pursuant to Belgian transparency [...]
Morphic to Present at the Wells Fargo Securities 2019 Healthcare Conference
30/08/2019
WALTHAM, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, [...]
Idera Pharmaceuticals to Present at the Baird 2019 Global Healthcare Conference
30/08/2019
EXTON, Pa., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the company will present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4, 2019 at 8: [...]
Vical Stockholders Approve Reverse Stock Split and Merger with Brickell
30/08/2019
• Merger Transaction Expected to Close August 31, 2019 SAN DIEGO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Vical Incorporated (“Vical”) (Nasdaq:VICL) announced that its stockholders voted to approve the proposals required to [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
30/08/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) reports the following transactions: 1. Details of the person discharging managerial responsibility / person closely associated a) Name Henrik Jacobi 2. Reason for the [...]
Afya Limited Reports 2Q19 Results
30/08/2019
NOVA LIMA, Brazil, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA), today reported financial and operating results for the second quarter of 2019. CEO Statement “The year of 2019 has been [...]
Total number of shares and voting rights in Zealand Pharma at August 31, 2019
30/08/2019
Company announcement – No. 28 / 2019 Copenhagen, August 30, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), a Copenhagen-based biotechnology company focused on the discovery and development [...]
Afya Limited Announces the Appointment of New Independent Member of Board of Directors and Audit Committee
30/08/2019
NOVA LIMA, Brazil, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Afya Limited, or Afya (Nasdaq: AFYA) today announced the appointment of Rafael Munerato de Almeida to its board of directors and audit committee as an independent [...]
Olainfarm Group’s financial performance in the first half reached new highs – sales were 66.4 million EUR; net profit jumps to 12.2 million EUR
30/08/2019
Group sales in the first half 2019 were 66.4 million EUR, which is 7% higher than a year earlier EBITDA margin for the first six month 2019 was 26%, up from 17% year ago Strong liquidity and decrease in leverage support [...]
Endonovo Therapeutics Appoints Dr. Geoffrey Abrams of Stanford University to Its Scientific Advisory Board
30/08/2019
LOS ANGELES, Aug. 30, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of noninvasive Electroceutical ® therapeutic devices [...]
MannKind Corporation to Present at H.C. Wainwright 21st Annual Global Investment Conference
30/08/2019
WESTLAKE VILLAGE, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases [...]
Vaxil Appoints New Chairman
30/08/2019
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Aug. 30, 2019 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (TSX VENTURE: VXL), an innovative immunotherapy biotech focused on cancer and infectious [...]
Y-mAbs Announces Data to be Presented at 2019 CTOS
30/08/2019
NEW YORK, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
HealthEquity Completes Acquisition of WageWorks
30/08/2019
Announces $80-100 Million Investment in Remarkable Service DRAPER, Utah, Aug. 30, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the “Company”) today completed its acquisition of WageWorks [...]
Ultragenyx to Present at Upcoming Investor Conferences
30/08/2019
NOVATO, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Biomerica Announces Fiscal Year End 2019 Financial Results
30/08/2019
IRVINE, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ), a global provider of advanced medical products, today reported net sales for the fiscal year 2019 were $5,200,682 versus net sales of $5 [...]
Cytovance Biologics to Participate in Boston’s BioProcess International Convention
30/08/2019
OKLAHOMA CITY, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Cytovance ® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the company will participate in the upcoming [...]
BBS Interim Report H1/2019
30/08/2019
BBS-Bioactive Bone Substitutes Plc (BBS) Interim Report January 1th – June 30th 2019 (unaudited) January-June shortly (comparison season 1-6/2018) Updates as required by the new Medical Device Regulation (MDR 2017/745) [...]

Pages